1007-385X
2016 Issue 5
Liquid biopsy and precision medicine for oncology
XU Yangmei;ZHENG Qiuhong;Key Laboratory of Tumor Biotherapy of Fujian Province;National Clinical Key Specialty of Tumor;Tumor Hospital of Fujian Province;Tumor Hospital Affiliated to Fujian Medical University;
XU Yangmei;ZHENG Qiuhong;Key Laboratory of Tumor Biotherapy of Fujian Province;National Clinical Key Specialty of Tumor;Tumor Hospital of Fujian Province;Tumor Hospital Affiliated to Fujian Medical University;
..............page:589-594
Exploration of using nanotechnologic detection for circulating tumor cell for diagnosis of early cancer
WANG Lei;HU Zhiyuan;Key Laboratory of Nano-biological Effects and Security;the National Center for Nanoscience;Chinese Academy of Science;National School of Development at Peking University;
WANG Lei;HU Zhiyuan;Key Laboratory of Nano-biological Effects and Security;the National Center for Nanoscience;Chinese Academy of Science;National School of Development at Peking University;
..............page:595-600
jian jue guan che zhi xing guo jia qi bu wei lian he fa bu de fa biao xue shu lun wen wu bu zhun de gui ding
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:600
Research progresses of circulating tumor DNA
GUO Qiaomei;LOU Jiatao;Laboratory Medicine;Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University;
GUO Qiaomei;LOU Jiatao;Laboratory Medicine;Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University;
..............page:601-608
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Str?nen E;Toebes M;Kelderman S;
Str?nen E;Toebes M;Kelderman S;
..............page:608
Some considerations on quality research and quality control of cell preparation products
WEI Wei;CHANG Weihong;Center for Drug Evaluation;China Food and Drug Administration;China Food and Drug Administration;
WEI Wei;CHANG Weihong;Center for Drug Evaluation;China Food and Drug Administration;China Food and Drug Administration;
..............page:609-612
Killing effect of NK cells modified with pCD19-CAR on B-cell lymphoma
YUAN Yuan;QIN Yang;YOU Fengtao;CHEN Dan;ZOU Jianxuan;ZHU Xuejun;LI Bingzong;YUAN Lei;MENG Huimin;ZHANG Bozhen;AN Gangli;YANG Lin;The Cyrus Tang Hematology Center;Soochow University;Department of Urology;Yunnan Cancer Hospital;Person Gen Biomedicine Co.;Ltd;Department of Hematology;Jiangsu Province Hospital of TCM;Department of Hematology;The Second Affiliated Hospital of Soochow University;Department of Hematology;Chinese PLA General Hospital;
YUAN Yuan;QIN Yang;YOU Fengtao;CHEN Dan;ZOU Jianxuan;ZHU Xuejun;LI Bingzong;YUAN Lei;MENG Huimin;ZHANG Bozhen;AN Gangli;YANG Lin;The Cyrus Tang Hematology Center;Soochow University;Department of Urology;Yunnan Cancer Hospital;Person Gen Biomedicine Co.;Ltd;Department of Hematology;Jiangsu Province Hospital of TCM;Department of Hematology;The Second Affiliated Hospital of Soochow University;Department of Hematology;Chinese PLA General Hospital;
..............page:613-619
Killing effect of NK-92MI cells modified with chimeric antigen receptor on HER2~+ breast carcinoma cell
KONG Xiao;QIN Yang;LI Jialu;YOU Fengtao;ZHU Xuejun;YUAN Lei;MENG Huimin;AN Gangli;YANG Lin;The Cyrus Tang Hematology Center & Collaborative Innovation Center of Hematology;Soochow University;Departmentof Urology;Cancer Hospital of Yunan Province;Suzhou Cancer Immunotherapy-Diagnosis and Nanomedicine Engineering Technology Center;Person Gen Biomedicine Co.;Ltd;Department of Hematology;Traditional Chinese Medicine Hospital of Jiangsu Province;Department of Hematology;Chinese PLA General Hospital;
KONG Xiao;QIN Yang;LI Jialu;YOU Fengtao;ZHU Xuejun;YUAN Lei;MENG Huimin;AN Gangli;YANG Lin;The Cyrus Tang Hematology Center & Collaborative Innovation Center of Hematology;Soochow University;Departmentof Urology;Cancer Hospital of Yunan Province;Suzhou Cancer Immunotherapy-Diagnosis and Nanomedicine Engineering Technology Center;Person Gen Biomedicine Co.;Ltd;Department of Hematology;Traditional Chinese Medicine Hospital of Jiangsu Province;Department of Hematology;Chinese PLA General Hospital;
..............page:620-625
Depletion of glucose or glutamine affects growth and apoptosis of melanoma cell A375
YU Tiantian;ZHANG Fan;LU Yao;LI Hongxia;XIE Min;LIU Qingping;LU Teng;QIN Jianzhong;CHI Yan;Key Laboratory of Carbohydrate and Lipid Metabolism in Liaoning Province;College of Life Science and Technology;Dalian University;
YU Tiantian;ZHANG Fan;LU Yao;LI Hongxia;XIE Min;LIU Qingping;LU Teng;QIN Jianzhong;CHI Yan;Key Laboratory of Carbohydrate and Lipid Metabolism in Liaoning Province;College of Life Science and Technology;Dalian University;
..............page:626-632
Inhibitory effect of recombinant adenovirus Ad5-CCL20 combined with hyperthermia on xenografts growth of colon carcinoma CT-26 cells in mice
ZHU Xujun;SU Ning;YAO Jun;XU Kai;LI Xinxing;WANG Weijun;HU Zhiqian;SUN Yanping;Department of General Surgery;Changzheng Hospital;Second Military Medical University;
ZHU Xujun;SU Ning;YAO Jun;XU Kai;LI Xinxing;WANG Weijun;HU Zhiqian;SUN Yanping;Department of General Surgery;Changzheng Hospital;Second Military Medical University;
..............page:633-639
wen gao zhong xu xie cheng xie ti de wai wen zi fu
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:639
Inhibition of down-regulating miR-221 expression to malignant biologic behaviors of cervical cancer cells and mechanism of the action
PAN Yulu;SHI Cuige;WU Shuxia;REN Xingye;Department of Obstetrics and Gynecology;5th People’s Hospital of Jinan;Laboratory of Cell Biology;Institute of Family Planning of China;
PAN Yulu;SHI Cuige;WU Shuxia;REN Xingye;Department of Obstetrics and Gynecology;5th People’s Hospital of Jinan;Laboratory of Cell Biology;Institute of Family Planning of China;
..............page:640-645
Effect of shRNA interfering expression of CDX2 gene on hepatic metastasis of colorectal cancer in nude mice
ZHENG Jianbao;LI Xiaobin;SUN Xuejun;WANG Xiaolong;WANG Wei;WEI Guangbing;CHEN Nanzheng;WANG Kai;Department of General Surgery;the First Affiliated Hospital of Xi’an Jiaotong University;the First Department of Thoracic Surgery;the First Affiliated Hospital of Xi’an Jiaotong University;
ZHENG Jianbao;LI Xiaobin;SUN Xuejun;WANG Xiaolong;WANG Wei;WEI Guangbing;CHEN Nanzheng;WANG Kai;Department of General Surgery;the First Affiliated Hospital of Xi’an Jiaotong University;the First Department of Thoracic Surgery;the First Affiliated Hospital of Xi’an Jiaotong University;
..............page:646-650
Up-regulation of human cannabinoid receptor 2 induces apoptosis of cervical cancer HeLa cells
TAN Xiaoling;LI Jing;ZHONG Xusu;Department of Gynaecology and Obstetrics;Xinqiao Hospital of Third Military Medical University;Laboratory Center;Chongqing Three Gorges Medical Hospital;
TAN Xiaoling;LI Jing;ZHONG Xusu;Department of Gynaecology and Obstetrics;Xinqiao Hospital of Third Military Medical University;Laboratory Center;Chongqing Three Gorges Medical Hospital;
..............page:651-655
Heparanase-mediated adhesion with vascular endothelial cell and trans-endothelial migration of hepatocellular carcinoma cells
CHEN Xiaopeng;JIANG Wen;ZHANG Wenjun;CUI Wei;Department of Hepatobiliary Surgery;Yijishan Hospital Affiliated to Wannan Medical College;
CHEN Xiaopeng;JIANG Wen;ZHANG Wenjun;CUI Wei;Department of Hepatobiliary Surgery;Yijishan Hospital Affiliated to Wannan Medical College;
..............page:656-662
re lie zhu he ben kan zhu bian cao xue tao yuan shi mian yi xi bao zhi liao yan jiu xiang mu rong huo 2016 nian du chen jia geng sheng ming ke xue jiang
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:662
Inhibitory effect of γ-aminobutyric acid on proliferation of colorectal cancer cells and its chemosensitization
XIONG Ying;JIANG Jing;ZHANG Yao;SONG Lihua;Department of Food Science and Engineering;Shanghai Jiaotong University;
XIONG Ying;JIANG Jing;ZHANG Yao;SONG Lihua;Department of Food Science and Engineering;Shanghai Jiaotong University;
..............page:663-669
Peripheral blood sCTLA-4:prognostic factor of patients with advanced non-small cell lung cancer
WU Libo;JIANG Yi;JIANG Weijie;LI Hegen;XU Ling;TIAN Jianhui;LIU Lingshuang;Department of Oncology;Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;
WU Libo;JIANG Yi;JIANG Weijie;LI Hegen;XU Ling;TIAN Jianhui;LIU Lingshuang;Department of Oncology;Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine;
..............page:670-674
Expression and methylation status of lncRNA XLOC_ 002319 in esophageal squamous cell carcinoma
LIANG Jia;KUANG Gang;LIU Shengnan;GUO Wei;SHEN Supeng;DING Chunyan;LI Huijie;DONG Zhiming;Cancer Institute of Hebei Province;the Fourth Hospital Affiliated to Hebei Medical University;Department of Oncology;Shijiazhuang City First People’ s Hospital;
LIANG Jia;KUANG Gang;LIU Shengnan;GUO Wei;SHEN Supeng;DING Chunyan;LI Huijie;DONG Zhiming;Cancer Institute of Hebei Province;the Fourth Hospital Affiliated to Hebei Medical University;Department of Oncology;Shijiazhuang City First People’ s Hospital;
..............page:675-681
Clinical efficacy of patients with advanced ovarian cancer treated with DC-CIK cytotherapy
ZHENG Jie;JIANG Longwei;YAO Lu;LU Xiao;YANG Aizhen;AI Yueqin;ZHANG Yan;ZHANG Chuang;HUANG Weiqian;GAO Yanrong;ZHAO Hua;HU Jianhua;JIA Shaochang;Department of Tumor Biotherapy;the 81th Hospital of PLA;
ZHENG Jie;JIANG Longwei;YAO Lu;LU Xiao;YANG Aizhen;AI Yueqin;ZHANG Yan;ZHANG Chuang;HUANG Weiqian;GAO Yanrong;ZHAO Hua;HU Jianhua;JIA Shaochang;Department of Tumor Biotherapy;the 81th Hospital of PLA;
..............page:682-687
ben kan dui wen gao zhong shi yan dong wu miao shu de yao qiu
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:687
Expression and clinical significance of PVT1 gene in blood of the patients with gastric cancer
REN Xianxian;XIAO Yongbiao;ZHANG Lei;XI Yu;XU Jie;PAN Zemin;LI Hongtao;LI Dongmei;Department of Biochemistry;School of Medicine;Shihezi University;Department of Digestive Tumor Surgery;1st People’s Hospital of Kashgar District;Department of Clinical Laboratory;1st Hospital Affiliated to School of Medicine;Shihezi University;Department of Cardiology;The 5th Hospital Affiliated to the Xinjiang Medical University;
REN Xianxian;XIAO Yongbiao;ZHANG Lei;XI Yu;XU Jie;PAN Zemin;LI Hongtao;LI Dongmei;Department of Biochemistry;School of Medicine;Shihezi University;Department of Digestive Tumor Surgery;1st People’s Hospital of Kashgar District;Department of Clinical Laboratory;1st Hospital Affiliated to School of Medicine;Shihezi University;Department of Cardiology;The 5th Hospital Affiliated to the Xinjiang Medical University;
..............page:688-691
Feasibility of nimotuzumab combined with radiotherapy and chemotherapy for long-term in the treatment of patients with local advanced nasopharyngeal carcinoma
WANG Fangzheng;JIANG Chuner;YE Zhimin;SUN Quanquan;YAN Fengqin;WANG Lei;QIN Weifeng;LI Bin;HU Fujun;FU Zhenfu;Department of Radiation Oncology;Zhejiang Cancer Hospital;Zhejiang Key Laboratory of Radiotherapy;Zhejiang Cancer Hospital;Department of Breast Surgery;Zhejiang Cancer Hospital;
WANG Fangzheng;JIANG Chuner;YE Zhimin;SUN Quanquan;YAN Fengqin;WANG Lei;QIN Weifeng;LI Bin;HU Fujun;FU Zhenfu;Department of Radiation Oncology;Zhejiang Cancer Hospital;Zhejiang Key Laboratory of Radiotherapy;Zhejiang Cancer Hospital;Department of Breast Surgery;Zhejiang Cancer Hospital;
..............page:692-697
Clinical characteristics and treatment analysis of advanced lacrimal gland carcinoma
GUI Lin;HE Xiaohui;HOU Lijie;PI Jinping;Cong Xiaoxia;Department of Medical Oncology;National Cancer Center/Cancer Hospital;Chinese Academy of Medical Sciences/Peking Union Medical College;Department of Medical Oncology;Beijing Sanhuan Cancer Hospitial;
GUI Lin;HE Xiaohui;HOU Lijie;PI Jinping;Cong Xiaoxia;Department of Medical Oncology;National Cancer Center/Cancer Hospital;Chinese Academy of Medical Sciences/Peking Union Medical College;Department of Medical Oncology;Beijing Sanhuan Cancer Hospitial;
..............page:698-702
Establishment of an endogastric xenograft tumor modal in nude mice and its detection by in vivo fluorescence imaging system
CAO Zhongyuan;ZHAO Zhenkai;XIANG Geng;NI Qingrong;CAI Yanhui;XI Yujing;ZHAO Jing;YAN Bo;School of Student Brigade;the Fourth Military Medical University;Deparment of Anesthesiology;Xijing Hospital;the Fourth Military Medical University;Department of Biochemistry and Molecular Biology;the Fourth Military Medical University;
CAO Zhongyuan;ZHAO Zhenkai;XIANG Geng;NI Qingrong;CAI Yanhui;XI Yujing;ZHAO Jing;YAN Bo;School of Student Brigade;the Fourth Military Medical University;Deparment of Anesthesiology;Xijing Hospital;the Fourth Military Medical University;Department of Biochemistry and Molecular Biology;the Fourth Military Medical University;
..............page:703-707
..............page:707
Research progress of the molecular targeted anti-tumor drugs in the era of precision medicine
xiong jia ; wei min jie ;
xiong jia ; wei min jie ;
..............page:708-713
T cell-mediated precision cancer immunotherapy
xu jing ; liu xia ; yang yi li ;
xu jing ; liu xia ; yang yi li ;
..............page:714-719
wen gao zhong ji liang dan wei shi yong de yao qiu
ben kan bian ji bu ;
ben kan bian ji bu ;
..............page:719
Progresses of anti-tumor research or chimeric antigen receptor modified CIK cells
yao wei zuo ; rao wei ; zhou hong zuo ;
yao wei zuo ; rao wei ; zhou hong zuo ;
..............page:720-726
Significance of the epigenetic modifications in cancer immunotherapy
zhou you ; kong xiang yin ; jiang jing ting ;
zhou you ; kong xiang yin ; jiang jing ting ;
..............page:727-732
The role of hypoxia-related microRNA-210 in malignant process of tumor
zhang wen hui ; song zuo ;
zhang wen hui ; song zuo ;
..............page:733-738
..............page:739-740